Hylek E - Search Results

1

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Ansell J, et al. Among authors: hylek e. Chest. 2008 Jun;133(6 Suppl):160S-198S. doi: 10.1378/chest.08-0670. Chest. 2008. PMID: 18574265

2

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Ageno W, et al. Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292. Chest. 2012. PMID: 22315269 Free PMC article. Review.

3

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. Ansell J, et al. Among authors: hylek e. Chest. 2004 Sep;126(3 Suppl):204S-233S. doi: 10.1378/chest.126.3_suppl.204S. Chest. 2004. PMID: 15383473

4

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.

Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM. Garcia D, et al. Chest. 2005 Jun;127(6):2049-56. doi: 10.1378/chest.127.6.2049. Chest. 2005. PMID: 15947319

5

National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation.

Dlott JS, George RA, Huang X, Odeh M, Kaufman HW, Ansell J, Hylek EM. Dlott JS, et al. Circulation. 2014 Apr 1;129(13):1407-14. doi: 10.1161/CIRCULATIONAHA.113.002601. Epub 2014 Feb 3. Circulation. 2014. PMID: 24493817

6

The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Garcia DA, Regan S, Crowther M, Hylek EM. Garcia DA, et al. J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. doi: 10.1016/j.jacc.2005.09.058. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487849 Free article.

7

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.

Dentali F, Marchesi C, Giorgi Pierfranceschi M, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Dentali F, et al. Among authors: hylek e. Thromb Haemost. 2011 Sep;106(3):429-38. doi: 10.1160/TH11-01-0052. Epub 2011 Jul 28. Thromb Haemost. 2011. PMID: 21800002

8

Nonadherence with INR monitoring and anticoagulant complications.

Witt DM, Delate T, Clark NP, Garcia DA, Hylek EM, Ageno W, Dentali F, Crowther MA. Witt DM, et al. Thromb Res. 2013 Aug;132(2):e124-30. doi: 10.1016/j.thromres.2013.06.006. Epub 2013 Jun 22. Thromb Res. 2013. PMID: 23800635

9

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.

Pokorney SD, Simon DN, Thomas L, Fonarow GC, Kowey PR, Chang P, Singer DE, Ansell J, Blanco RG, Gersh B, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators. Pokorney SD, et al. Among authors: hylek em. Am Heart J. 2015 Jul;170(1):141-8, 148.e1. doi: 10.1016/j.ahj.2015.03.017. Epub 2015 Apr 1. Am Heart J. 2015. PMID: 26093875 Free article.

10

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

O'Brien EC, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM. O'Brien EC, et al. Among authors: hylek em. J Am Heart Assoc. 2018 Jun 9;7(12):e006391. doi: 10.1161/JAHA.117.006391. J Am Heart Assoc. 2018. PMID: 29886422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page